Drugs Made In America Acquisition Corp. (DMAA) stock
Close on Nov 16, 2026Market cap $264.62MP/E –Yield –
Earnings
Drugs Made In America Acquisition's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Drugs Made In America Acquisition's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Drugs Made In America Acquisition has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Drugs Made In America Acquisition puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Drugs Made In America Acquisition filed with the SEC as exhibits to Form 8-K or 6-K
See a number that looks wrong?